2 Years • 15 Seats • PCI Approved • NAAC A Grade • Komarapalayam, Namakkal
2 Years
4 semesters, full time
15 Seats
of 90 across 6 M.Pharm specialisations
₹75,000/year
management quota tuition
B.Pharm, 50%
45% for SC/ST, GPAT preferred
A medicine cannot be sold because it works. It can be sold because a regulator has been shown, in a prescribed format, that it works, that it is safe, and that it is made under controlled conditions. Assembling that proof and defending it is the work of regulatory affairs.
M.Pharm Pharmaceutical Regulatory Affairs is a two-year postgraduate specialisation that teaches the law, the formats and the submission routes that govern a pharmaceutical product from development through approval and across its whole marketed life. Learners study the Drugs and Cosmetics Act 1940 and its Rules, Schedule M and good manufacturing practice, the Common Technical Document and eCTD structure, CDSCO and DCGI procedures, clinical trial regulation under the New Drugs and Clinical Trials Rules 2019, pharmacovigilance and periodic safety reporting, labelling and packaging compliance, and the pathways of the international agencies Indian exporters file with.
Who this suits. Regulatory affairs is a writing, reading and compliance discipline more than a laboratory one. It rewards precision, patience with documentation, and the ability to read a guideline and work out exactly what it demands. If you would rather be at a bench than at a desk, consider Pharmaceutics, Pharmacology or Pharmaceutical Chemistry instead.
Semester content follows the Pharmacy Council of India regulations for M.Pharm and the affiliating university syllabus. Confirm the current syllabus with the department before admission.
India — new drug approval, import licences, clinical trial permission
India — manufacturing and sale licences, Schedule M inspections
United States — ANDA, NDA, DMF submissions for exporters
European Union — centralised and decentralised procedures
United Kingdom — post-Brexit national submissions
Global tenders and public health procurement
ICH guidelines and the Common Technical Document format are taught as the common framework that links these agencies, because a single dossier structure serves most of them with regional adaptation.
Pharmaceutical manufacturers, CROs, regulatory consultancies
Formulation and API companies preparing CTD submissions
Export-focused manufacturers filing with US FDA, EMA, WHO
Packaging development and quality assurance teams
Safety departments, CROs, marketing authorisation holders
GMP-regulated manufacturing sites
Clinical research organisations and hospital trial sites
Consultancies tracking guideline and law changes
The median salary of placed M.Pharm graduates from JKKN College of Pharmacy was ₹6,23,000 for the 2023-24 graduating batch, with 37 of 49 graduates placed and 6 continuing to higher studies.
Source: JKKN College of Pharmacy NIRF 2025 submission to the Ministry of Education, published at /pdf/NIRF-2025-Pharmacy.pdf. This is the college-wide M.Pharm figure; Regulatory Affairs is a new specialisation and does not yet have its own placement history.
| Seats, this specialisation | 15 |
| Total M.Pharm intake | 90 across 6 specialisations |
| Tuition, management quota | ₹75,000 / year |
| Tuition, government quota | Tamil Nadu fee committee norms |
| Duration | 2 years, 4 semesters |
Hostel, transport and examination fees are additional. Confirm the current year fee on the fee structure page or on +91 93458 55001.
Drug approval, dossiers and compliance
15 seats
Six specialisations, 15 seats each, 90 seats in total. See the M.Pharm programme page for a full comparison, or the M.Pharm admission page for the 2026-27 application process.
M.Pharm Pharmaceutical Regulatory Affairs is a 2-year postgraduate specialisation that teaches how a medicine is approved, licensed and kept compliant. The course covers Indian drug law under the Drugs and Cosmetics Act 1940 and its Rules, CDSCO and DCGI submission routes, Common Technical Document and eCTD dossier preparation, clinical trial regulation under the New Drugs and Clinical Trials Rules 2019, pharmacovigilance reporting, labelling and packaging compliance, and the regulatory pathways of major agencies including US FDA, EMA and WHO prequalification.
Candidates must hold a B.Pharm degree from a Pharmacy Council of India approved institution with a minimum of 50 percent aggregate marks, relaxed to 45 percent for SC and ST candidates. A valid GPAT score is preferred. Admission is through merit and the applicable Tamil Nadu counselling process for management and government quota seats.
JKKN College of Pharmacy offers 15 seats in M.Pharm Pharmaceutical Regulatory Affairs. It is one of six M.Pharm specialisations at the college, which together carry a total sanctioned intake of 90 seats.
Graduates work as Regulatory Affairs Associates and Executives, dossier and CMC writers, drug regulatory submission specialists, labelling and artwork compliance officers, pharmacovigilance and drug safety associates, quality assurance and compliance officers, and clinical trial regulatory coordinators. Employers include Indian and multinational pharmaceutical manufacturers, contract research organisations, regulatory consultancies and medical device companies.
Pharmaceutical Analysis is a laboratory specialisation focused on analytical method development, validation and quality control testing. Pharmaceutical Regulatory Affairs is a documentation and compliance specialisation focused on getting a product approved and keeping it approved. Analysis generates the data; Regulatory Affairs assembles that data into a dossier a regulator will accept. Both are needed to bring a medicine to market, and regulatory roles are largely desk-based rather than bench-based.
Regulatory Affairs suits candidates who are strong at technical writing, detail-oriented documentation and interpreting legal and scientific guidelines, and who prefer office and compliance work to laboratory work. Every marketed medicine requires continuous regulatory maintenance, so the function exists at every pharmaceutical manufacturer regardless of company size. Candidates who prefer bench research should consider Pharmaceutics, Pharmacology or Pharmaceutical Chemistry instead.
Yes. Seats are available under both government and management quota. The management quota tuition fee is Rs 75,000 per year, the same as the other five M.Pharm specialisations at JKKN. Government quota fees follow Tamil Nadu fee committee norms. Admission enquiries can be made on +91 93458 55001.
The course covers CDSCO and the Drugs Controller General of India as the primary Indian authorities, State Licensing Authorities for manufacturing and sale licences, and the international agencies most relevant to Indian exporters — the US FDA, the European Medicines Agency, the UK MHRA, Health Canada, the TGA in Australia and WHO prequalification. ICH guidelines and the Common Technical Document format that underpins all of them are taught as the common framework.
15 seats • PCI approved • NAAC A Grade • Komarapalayam, Namakkal district
